Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada.
Cancer Res. 2023 Nov 1;83(21):3517-3528. doi: 10.1158/0008-5472.CAN-22-3620.
DICER1 is an RNase III enzyme essential for miRNA biogenesis through cleaving precursor-miRNA hairpins. Germline loss-of-function DICER1 mutations underline the development of DICER1 syndrome, a rare genetic disorder that predisposes children to cancer development in organs such as lung, gynecologic tract, kidney, and brain. Unlike classical tumor suppressors, the somatic "second hit" in DICER1 syndrome-associated cancers does not fully inactivate DICER1 but impairs its RNase IIIb activity only, suggesting a noncanonical two-hit hypothesis. Here, we developed a genetically engineered conditional compound heterozygous Dicer1 mutant mouse strain that fully recapitulates the biallelic DICER1 mutations in DICER1 syndrome-associated human cancers. Crossing this tool strain with tissue-specific Cre strains that activate Dicer1 mutations in gynecologic tract cells at two distinct developmental stages revealed that embryonic biallelic Dicer1 mutations caused infertility in females by disrupting oviduct and endometrium development and ultimately drove cancer development. These multicystic tubal and intrauterine tumors histologically resembled a subset of DICER1 syndrome-associated human cancers. Molecular analysis uncovered accumulation of additional oncogenic events (e.g., aberrant p53 expression, Kras mutation, and Myc activation) in murine Dicer1 mutant tumors and validated miRNA biogenesis defects in 5P miRNA strand production, of which, loss of let-7 family miRNAs was identified as a putative key player in transcriptomic rewiring and tumor development. Thus, this DICER1 syndrome-associated cancer model recapitulates the biology of human cancer and provides a unique tool for future investigation and therapeutic development.
Generation of a Dicer1 mutant mouse model establishes the oncogenicity of missense mutations in the DICER1 RNase IIIb domain and provides a faithful model of DICER1 syndrome-associated cancer for further investigation.
DICER1 是一种 RNase III 酶,通过切割前体 miRNA 发夹对 miRNA 的生物发生至关重要。种系缺失功能的 DICER1 突变强调了 DICER1 综合征的发展,这是一种罕见的遗传疾病,使儿童易患肺、妇科生殖道、肾脏和大脑等器官的癌症发展。与经典的肿瘤抑制因子不同,DICER1 综合征相关癌症中的体细胞“二次打击”并没有完全使 DICER1 失活,而是仅损害其 RNase IIIb 活性,这表明存在非典型的双打击假说。在这里,我们开发了一种遗传工程条件性杂合 Dicer1 突变小鼠品系,该品系完全重现了 DICER1 综合征相关人类癌症中的双等位基因突变。将这种工具品系与组织特异性 Cre 菌株杂交,在两个不同的发育阶段激活妇科生殖道细胞中的 Dicer1 突变,结果表明,胚胎双等位基因突变通过破坏输卵管和子宫内膜发育导致雌性不育,并最终导致癌症发展。这些多囊管状和子宫内肿瘤在组织学上类似于 DICER1 综合征相关人类癌症的一部分。分子分析揭示了在小鼠 Dicer1 突变肿瘤中积累了额外的致癌事件(例如,异常的 p53 表达、Kras 突变和 Myc 激活),并验证了 5P miRNA 链产生中的 miRNA 生物发生缺陷,其中,let-7 家族 miRNA 的缺失被鉴定为转录组重排和肿瘤发展的潜在关键因素。因此,这种 DICER1 综合征相关的癌症模型再现了人类癌症的生物学,并为未来的研究和治疗开发提供了独特的工具。
Dicer1 突变小鼠模型的产生确立了 DICER1 RNase IIIb 结构域中错义突变的致癌性,并为进一步研究提供了 DICER1 综合征相关癌症的忠实模型。